The Dow posted its largest decline since August as the VIX spiked and oil prices topped $94, fueling investor anxiety ahead of…
Nasdaq 100 rebalancing and SpaceX lockup expirations set to increase market liquidity, with analysts projecting continued growth in the company's index weighting.
Rising financial pessimism among US households and concerns over future unemployment rates signal potential headwinds for equity markets as investors await key…
Wall Street prepares for a cautious session as geopolitical tensions drive oil prices higher and investors recalibrate expectations for Federal Reserve monetary…
Wall Street firms push S&P 500 targets toward 8,400, even as analysts warn that low volatility, persistent inflation, and narrow earnings leadership…
Despite emotional market volatility, history shows that a disciplined, long-term buy-and-hold strategy using S&P 500 ETFs remains the most effective path to…
The S&P 500 rallied 15.2% in Q2 2026, fueled by AI hardware demand, while the Harbor Mid Cap Value Fund outperformed its…
Quantum stocks Rigetti and D-Wave jump on $100M government funding deals, while IonQ boosts 2026 revenue guidance ahead of its investor day.
The S&P 500 maintains momentum in 2026, with historical data indicating that investors who remain in the market after record highs capture…
Dow futures fell 400 points while Brent crude surged near $100 a barrel as geopolitical instability between the U.S. and Iran intensifies,…
Dyne Therapeutics shares fell 31% in premarket trading on no confirmed news, decoupling from the broader market as investors await further updates…
Biohaven shares fell 1.9% as RBC lowered its price target to $19, citing valuation concerns and clinical risks ahead of a critical…